Walgreens Boots Alliance Inc (WBA) is Reiterated by Deutsche Bank to Buy, Raises Price Target to $ 94

Walgreens Boots Alliance Inc (WBA) was Reiterated by Deutsche Bank to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 94 from a previous price target of $93 . Deutsche Bank advised their investors in a research report released on Aug 30, 2016.

Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.

On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.

Walgreens Boots Alliance Inc opened for trading at $79.8 and hit $80.86 on the upside on Monday, eventually ending the session at $80.35, with a gain of 1.21% or 0.96 points. The heightened volatility saw the trading volume jump to 34,67,800 shares. Company has a market cap of $86,964 M.

In a different news, on Jul 27, 2016, William C Foote (director) sold 2,067 shares at $81.35 per share price. According to the SEC, on Jul 18, 2016, Kathleen Wilson-thompson (EVP and Global Chief HRO) sold 29,695 shares at $83.00 per share price. On Apr 18, 2016, George Rollo Fairweather (EVP and Global CFO) sold 50,000 shares at $81.52 per share price, according to the Form-4 filing with the securities and exchange commission.

Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.

Walgreens Boots Alliance Inc

Leave a Reply

Walgreens Boots Alliance Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Walgreens Boots Alliance Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.